Trials & R&D · first seen yesterday, updated yesterday

First of Amgen’s Phase III Sjögren’s disease trials succeeds

1 outlet Amgen

Amgen is running a second Phase III study of dazodalibep in Sjögren's disease as it eyes a spot in a lacking market. The post First of Amgen’s Phase III Sjögren’s disease trials succeeds appeared first on Clinical Trials Arena .

Summary from Clinical Trials Arena.

Coverage 1 article · 1 outlet

Clinical Trials Arena yesterday
First of Amgen’s Phase III Sjögren’s disease trials succeeds